Stenocare A/S (CPH:STENO)
Denmark · Delayed Price · Currency is DKK 1.110
+0.308 (38.40%)
Mar 26, 2026, 12:07 PM CET
Stenocare Market Cap
Stenocare has a market cap or net worth of 34.64 million as of March 26, 2026. Its market cap has increased by 305.12% in one year.
Market Cap
34.64M
Enterprise Value
35.84M
Revenue
7.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.11
Market Cap Chart
Since May 18, 2020, Stenocare's market cap has decreased from 326.86M to 34.64M, a decrease of -89.40%. That is a compound annual growth rate of -31.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 34.64M | -45.81% |
| Dec 30, 2025 | 63.93M | 146.13% |
| Dec 30, 2024 | 25.97M | -43.63% |
| Dec 29, 2023 | 46.08M | -56.10% |
| Dec 30, 2022 | 104.96M | -11.04% |
| Dec 30, 2021 | 117.98M | -47.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| May 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.05T |
| Genmab | 100.50B |
| Coloplast | 96.10B |
| ALK-Abelló | 45.64B |
| BioPorto | 450.54M |
| Pharma Equity Group | 103.61M |
| ViroGates | 102.56M |
| Scandinavian Medical Solutions | 94.26M |